Tennessee Federal Judge Dismisses Invokana Kidney Injury Claims

(June 22, 2016, 12:09 PM EDT) -- JACKSON, Tenn. — A Tennessee federal judge on June 6 dismissed with prejudice most of a plaintiff’s kidney injury claims in an Invokana diabetes drug case but allowed him to refile claims under the Tennessee Product Liability Act (Wardell Fleming v. Janssen Pharmaceuticals Inc., et al., No. 15-2799, W.D. Tenn., Jackson Div.; 2016 U.S. Dist. LEXIS 73194).

(Order available. Document #29-160623-015R.)

In 2015, Wardell Fleming sued Invokana co-promoters Janssen Pharmaceuticals Inc. and Mitsubishi Tanabe Pharma Corp. in the U.S. District Court for the Western District of...
To view the full article, register now.